RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids

Zhenlong Zheng, Lianhua Zhu, Xianglan Zhang, Lianhua Li, Sook Moon, MiRyung Roh, Zhehu Jin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Runt-related transcription factor 3 (RUNX3) has recently been reported to be a possible predictor of sensitivity of cancer cells for photodynamic therapy (PDT), a promising therapeutic modality for keloids. In this study, we aimed to elucidate the implications of RUNX3 for keloid pathogenesis and sensitivity to pheophorbide a-based PDT (Pa-PDT). RUNX3 and proliferating cell nuclear antigen (PCNA) expression were examined in 6 normal skin samples and 32 keloid tissue samples by immunohistochemistry. We found that RUNX3 expression was detected more often in keloid tissues than in dermis of normal skin. In keloid tissues, RUNX3 expression was significantly increased in patients presenting with symptoms of pain or pruritus, and was also significantly related to PCNA expression. The therapeutic effect of Pa-PDT was comparatively investigated in keloid fibroblasts (KFs) with and without RUNX3 expression. Significant differences were found after Pa-PDT between KFs with and without RUNX3 expression in cell viability, proliferative ability, type I collagen expression, generation of reactive oxygen species (ROS), and apoptotic cell death. In addition, RUNX3 expression was significantly decreased after Pa-PDT in KFs, and KFs with downregulation of RUNX3 showed significantly increased cell viability after Pa-PDT. Pa-PDT may be a potential therapeutic modality for keloids, and RUNX3, as a possible contributor to keloid pathogenesis, may improve sensitivity to Pa-PDT in KFs.

Original languageEnglish
Pages (from-to)67-75
Number of pages9
JournalLasers in Medical Science
Volume30
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Keloid
Photochemotherapy
Fibroblasts
Proliferating Cell Nuclear Antigen
pheophorbide a
Cell Survival
Transcription Factor 3
Skin
Aptitude
Therapeutic Uses
Pruritus
Dermis
Cell- and Tissue-Based Therapy
Collagen Type I
1-phenyl-3,3-dimethyltriazene
Reactive Oxygen Species
Cell Death
Down-Regulation

All Science Journal Classification (ASJC) codes

  • Surgery
  • Dermatology

Cite this

Zheng, Zhenlong ; Zhu, Lianhua ; Zhang, Xianglan ; Li, Lianhua ; Moon, Sook ; Roh, MiRyung ; Jin, Zhehu. / RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids. In: Lasers in Medical Science. 2014 ; Vol. 30, No. 1. pp. 67-75.
@article{e9b5a495c5ae4f908d6c21375857266c,
title = "RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids",
abstract = "Runt-related transcription factor 3 (RUNX3) has recently been reported to be a possible predictor of sensitivity of cancer cells for photodynamic therapy (PDT), a promising therapeutic modality for keloids. In this study, we aimed to elucidate the implications of RUNX3 for keloid pathogenesis and sensitivity to pheophorbide a-based PDT (Pa-PDT). RUNX3 and proliferating cell nuclear antigen (PCNA) expression were examined in 6 normal skin samples and 32 keloid tissue samples by immunohistochemistry. We found that RUNX3 expression was detected more often in keloid tissues than in dermis of normal skin. In keloid tissues, RUNX3 expression was significantly increased in patients presenting with symptoms of pain or pruritus, and was also significantly related to PCNA expression. The therapeutic effect of Pa-PDT was comparatively investigated in keloid fibroblasts (KFs) with and without RUNX3 expression. Significant differences were found after Pa-PDT between KFs with and without RUNX3 expression in cell viability, proliferative ability, type I collagen expression, generation of reactive oxygen species (ROS), and apoptotic cell death. In addition, RUNX3 expression was significantly decreased after Pa-PDT in KFs, and KFs with downregulation of RUNX3 showed significantly increased cell viability after Pa-PDT. Pa-PDT may be a potential therapeutic modality for keloids, and RUNX3, as a possible contributor to keloid pathogenesis, may improve sensitivity to Pa-PDT in KFs.",
author = "Zhenlong Zheng and Lianhua Zhu and Xianglan Zhang and Lianhua Li and Sook Moon and MiRyung Roh and Zhehu Jin",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s10103-014-1614-4",
language = "English",
volume = "30",
pages = "67--75",
journal = "Lasers in Medical Science",
issn = "0268-8921",
publisher = "Springer London",
number = "1",

}

RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids. / Zheng, Zhenlong; Zhu, Lianhua; Zhang, Xianglan; Li, Lianhua; Moon, Sook; Roh, MiRyung; Jin, Zhehu.

In: Lasers in Medical Science, Vol. 30, No. 1, 01.01.2014, p. 67-75.

Research output: Contribution to journalArticle

TY - JOUR

T1 - RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids

AU - Zheng, Zhenlong

AU - Zhu, Lianhua

AU - Zhang, Xianglan

AU - Li, Lianhua

AU - Moon, Sook

AU - Roh, MiRyung

AU - Jin, Zhehu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Runt-related transcription factor 3 (RUNX3) has recently been reported to be a possible predictor of sensitivity of cancer cells for photodynamic therapy (PDT), a promising therapeutic modality for keloids. In this study, we aimed to elucidate the implications of RUNX3 for keloid pathogenesis and sensitivity to pheophorbide a-based PDT (Pa-PDT). RUNX3 and proliferating cell nuclear antigen (PCNA) expression were examined in 6 normal skin samples and 32 keloid tissue samples by immunohistochemistry. We found that RUNX3 expression was detected more often in keloid tissues than in dermis of normal skin. In keloid tissues, RUNX3 expression was significantly increased in patients presenting with symptoms of pain or pruritus, and was also significantly related to PCNA expression. The therapeutic effect of Pa-PDT was comparatively investigated in keloid fibroblasts (KFs) with and without RUNX3 expression. Significant differences were found after Pa-PDT between KFs with and without RUNX3 expression in cell viability, proliferative ability, type I collagen expression, generation of reactive oxygen species (ROS), and apoptotic cell death. In addition, RUNX3 expression was significantly decreased after Pa-PDT in KFs, and KFs with downregulation of RUNX3 showed significantly increased cell viability after Pa-PDT. Pa-PDT may be a potential therapeutic modality for keloids, and RUNX3, as a possible contributor to keloid pathogenesis, may improve sensitivity to Pa-PDT in KFs.

AB - Runt-related transcription factor 3 (RUNX3) has recently been reported to be a possible predictor of sensitivity of cancer cells for photodynamic therapy (PDT), a promising therapeutic modality for keloids. In this study, we aimed to elucidate the implications of RUNX3 for keloid pathogenesis and sensitivity to pheophorbide a-based PDT (Pa-PDT). RUNX3 and proliferating cell nuclear antigen (PCNA) expression were examined in 6 normal skin samples and 32 keloid tissue samples by immunohistochemistry. We found that RUNX3 expression was detected more often in keloid tissues than in dermis of normal skin. In keloid tissues, RUNX3 expression was significantly increased in patients presenting with symptoms of pain or pruritus, and was also significantly related to PCNA expression. The therapeutic effect of Pa-PDT was comparatively investigated in keloid fibroblasts (KFs) with and without RUNX3 expression. Significant differences were found after Pa-PDT between KFs with and without RUNX3 expression in cell viability, proliferative ability, type I collagen expression, generation of reactive oxygen species (ROS), and apoptotic cell death. In addition, RUNX3 expression was significantly decreased after Pa-PDT in KFs, and KFs with downregulation of RUNX3 showed significantly increased cell viability after Pa-PDT. Pa-PDT may be a potential therapeutic modality for keloids, and RUNX3, as a possible contributor to keloid pathogenesis, may improve sensitivity to Pa-PDT in KFs.

UR - http://www.scopus.com/inward/record.url?scp=84939881438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939881438&partnerID=8YFLogxK

U2 - 10.1007/s10103-014-1614-4

DO - 10.1007/s10103-014-1614-4

M3 - Article

C2 - 24957188

AN - SCOPUS:84939881438

VL - 30

SP - 67

EP - 75

JO - Lasers in Medical Science

JF - Lasers in Medical Science

SN - 0268-8921

IS - 1

ER -